CEO W. Paterson shares with 180 Markets the successful transition of Anteris into a Structural Heart Company and the benefits of the DurAVR™ Heart Valve.
This website may use cookies to analyze your traffic on this site. Anonymised data from the site may be supplied to social media, advertising and analytics partners who may combine it with other information that you’ve provided or that they’ve collected from your use of their services
